Agreement secures additional U.S. manufacturing capacity to help ensure patient access to medicineHOLLY SPRINGS, N.C., April 23, 2025 -- ...

Click here to jump right to our list of Canadian grocery brands Trump's tariffs require companies importing products from Canada to pay a 25 per cent fee to U.S. Customs and Border Protection, which ...

What just happened? Memory chipmaker Micron Technology has announced it will impose a surcharge on certain products starting Wednesday. According to four sources familiar with the matter who spoke ...

The sale of counterfeit branded goods is strictly prohibited on Shopee. But some sellers are trying to get away with it by concealing the brand's logo on the products to evade detection. To illustrate ...

© 2025 NBCUniversal Media, LLCApple®, Apple logo® and App Store® are registered trademarks of Apple Inc.

That second paragraph shows how potentially innovative Ive’s new project is, as The Information’s sources seem to have trouble even making a comparison to existing products. The idea of it ...

Pamalican Asset Management just snagged 6,900 shares of Regeneron Pharmaceuticals, making the biotech giant its 16th largest holding. This $4.9 million investment joins a stampede of institutional ...

Investigators assessed silmitasertib monotherapy in patients who had failed first-line hedgehog pathway inhibitors, with 27.3% also failing second-line PD-1 inhibitors such as cemiplimab (Libtayo) or ...

Notably, most of these products were discovered and developed internally (e.g., Eylea, Libtayo, Praluent, and Evkeeza). Dupixent was invented with the help of Regeneron’s VelocImmune technology ...

Inflation-weary Americans may soon find they're paying more for a host of products after President Trump announced two new types of tariffs on April 2, a day he termed "Liberation Day" because he ...

In this article, we are going to take a look at where Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) stands against other most profitable biotech stocks to buy right now. With improved market ...

Regeneron's main product is Duxipent, an autoimmune disease drug. It sells Libtayo, a cancer drug that recently got approved for a new medical indication. Both drugs are sold through a partnership ...